# The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus

> **NCT07334002** · NA · NOT_YET_RECRUITING · sponsor: **Sisli Hamidiye Etfal Training and Research Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Tinnitus
- Neural Therapy of Huneke

## Interventions

- **PROCEDURE:** Neural Therapy of Huneke
- **DRUG:** Betahistine 24 mg bid (Betaserc)

## Key facts

- **NCT ID:** NCT07334002
- **Lead sponsor:** Sisli Hamidiye Etfal Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2026-05-15
- **Final completion:** 2026-05-26
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07334002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07334002, "The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07334002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*